Genevieve Laforet

Company: Aspa Therapeutics

Job title: Vice President - Clinical Development

Seminars:

Complement Activation & Thrombotic Microangiopathy Associated with AAV Gene Therapy 1:30 pm

Overview of the complement system and complementopathies Thrombotic microangiopathy (TMA) associated with AAV gene therapy: atypical hemolytic-uremic syndrome (aHUS) Case characteristics of AAV-associated TMA/aHUS Surveillance, diagnosis and managementRead more

day: Day Two